THE EFFECT OF LOW-DOSE RECOMBINANT HUMAN GROWTH-HORMONE REPLACEMENT ON REGIONAL FAT DISTRIBUTION, INSULIN SENSITIVITY, AND CARDIOVASCULAR RISK-FACTORS IN HYPOPITUITARY ADULTS

被引:233
作者
WEAVER, JU
MONSON, JP
NOONAN, K
JOHN, WG
EDWARDS, A
EVANS, KA
CUNNINGHAM, J
机构
[1] ROYAL LONDON HOSP & MED COLL, DEPT ENDOCRINOL, LONDON E1 1BB, ENGLAND
[2] ROYAL LONDON HOSP & MED COLL, DEPT CLIN BIOCHEM, LONDON E1 1BB, ENGLAND
[3] ROYAL LONDON HOSP & MED COLL, DEPT NEPHROL, LONDON E1 1BB, ENGLAND
关键词
D O I
10.1210/jc.80.1.153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GH deficiency is associated with increased cardiovascular morbidity, which may be determined by alterations in vascular risk factors. We report the effect of partially treated hypopituitarism and subsequent GH replacement (mean dose, 0.2 IU/kg.week) on putative cardiovascular risk factors in 22 nondiabetic hypopituitary subjects in a 6-month, double blind, controlled study (active/placebo ratio, 11:11). All patients were subsequently treated with GH for a further 6 months. Total fat, percent body fat, and central fat were measured by dual energy x-ray absorptiometry. The hypopituitary patients had increased percent fat (P = 0.03) and central fat (P < 0.01) compared with body mass index-matched controls. Before GH treatment, fasting (total) and specific insulin positively correlated with body mass index (P = 0.02 and P < 0.001, respectively), waist/hip ratio (P = 0.05 and P = 0.01), and central fat (P = 0.03 and P = 0.003). Specific insulin and insulin sensitivity (IS), calculated by homeostatic model of assessment, were related to total fat (P < 0.001 and P = 0.02). GH treatment for 6 months led to a reduction in total fat (P < 0.02), percent fat (P = 0.002), central fat (P = 0.012), waist/hip ratio (P < 0.05), total cholesterol (P = 0.03), and apolipoprotein-B (P = 00001), as well as a decrease in the IS from 36.98 (range, 12-100%) to 25% (range, 2.5-55%; P = 0.0002). This was paralleled by a rise in fasting (total) and specific insulin (P = 0.016 and P = 0.002). The degree of correlation among indices of IS, body composition, and fat distribution increased after GH treatment. Fasting plasma glucose rose significantly, but was within the reference range. During 12 months of GH therapy, a significant increase in serum lipoprotein-(a) was observed (P < 0.05). Although GH has beneficial effects on central adiposity and lipid fractions, it is also associated with a decrease in IS; these effects may vary between individuals.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 39 条
  • [1] ANGELIN B, 1992, ACTA PAEDIATR, V81, P67
  • [2] TREATMENT OF ADULTS WITH GROWTH-HORMONE (GH) DEFICIENCY WITH RECOMBINANT HUMAN GH
    BENGTSSON, BA
    EDEN, S
    LONN, L
    KVIST, H
    STOKLAND, A
    LINDSTEDT, G
    BOSAEUS, I
    TOLLI, J
    SJOSTROM, L
    ISAKSSON, OGP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (02) : 309 - 317
  • [3] BESHYAH SA, 1991, J ENDOCRINOL S, V131, P95
  • [4] THE EFFECT OF GROWTH-HORMONE ADMINISTRATION IN GROWTH-HORMONE DEFICIENT ADULTS ON BONE, PROTEIN, CARBOHYDRATE AND LIPID HOMEOSTASIS, AS WELL AS ON BODY-COMPOSITION
    BINNERTS, A
    SWART, GR
    WILSON, JHP
    HOOGERBRUGGE, N
    POLS, HAP
    BIRKENHAGER, JC
    LAMBERTS, SWJ
    [J]. CLINICAL ENDOCRINOLOGY, 1992, 37 (01) : 79 - 87
  • [5] GROWTH-HORMONE TREATMENT IMPROVES SERUM-LIPIDS AND LIPOPROTEINS IN ADULTS WITH GROWTH-HORMONE DEFICIENCY
    CUNEO, RC
    SALOMON, F
    WATTS, GF
    HESP, R
    SONKSEN, PH
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (12): : 1519 - 1523
  • [6] SERUM-LIPID LEVELS IN GROWTH HORMONE-DEFICIENT MEN
    DEBOER, H
    BLOK, GJ
    VOERMAN, HJ
    PHILLIPS, M
    SCHOUTEN, JA
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (02): : 199 - 203
  • [7] EFFECT OF GROWTH-HORMONE TREATMENT ON HORMONAL PARAMETERS, BODY-COMPOSITION AND STRENGTH IN ATHLETES
    DEYSSIG, R
    FRISCH, H
    BLUM, WF
    WALDHOR, T
    [J]. ACTA ENDOCRINOLOGICA, 1993, 128 (04): : 313 - 318
  • [8] GROWTH-HORMONE DEFICIENCY IN LITTLE MICE RESULTS IN ABERRANT BODY-COMPOSITION, REDUCED INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 (IGFBP-3), BUT DOES NOT AFFECT IGFBP-2, IGFBP-1 OR IGFBP-4
    DONAHUE, LR
    BEAMER, WG
    [J]. JOURNAL OF ENDOCRINOLOGY, 1993, 136 (01) : 91 - 104
  • [9] GROWTH-HORMONE TREATMENT OF GROWTH HORMONE-DEFICIENT ADULTS RESULTS IN A MARKED INCREASE IN LP(A) AND HDL CHOLESTEROL CONCENTRATIONS
    EDEN, S
    WIKLUND, O
    OSCARSSON, J
    ROSEN, T
    BENGTSSON, BA
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (02): : 296 - 301
  • [10] ASSESSMENT OF INSULIN, GLUCOSE AND LIPIDS IN ISCHEMIC THROMBOTIC CEREBROVASCULAR-DISEASE
    GERTLER, MM
    LEETMA, HE
    KOUTROUBY, RJ
    JOHNSON, ED
    [J]. STROKE, 1975, 6 (01) : 77 - 84